Transfection Reagents & Equipment Market - Global Forecast 2026-2032 | Market to Reach USD 2.43 Billion as Cell and Gene Therapy, mRNA, CRISPR, and GMP Automation Drive 7.18% CAGR
Dublin, Nov. 19, 2026 (GLOBE NEWSWIRE) -- "Transfection Reagents & Equipment Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.
This market research report examines the global transfection reagents and equipment market, projected to grow from USD 1.60 billion in 2026 to USD 2.43 billion by 2032 at a CAGR of 7.18%. It analyzes the technologies, applications, regional dynamics, and competitive priorities shaping nucleic acid and protein delivery across life sciences research, biomanufacturing, and therapeutic development.
Market Growth and Demand Drivers
Transfection technologies enable nucleic acids, proteins, and gene-editing systems to enter cells for applications spanning cell and gene therapy, RNA therapeutics, vaccine research, oncology, immunology, functional genomics, and synthetic biology. Demand is supported by the need for reliable delivery into primary cells, stem cells, immune cells, and other difficult-to-transfect cell lines.
Clinical validation of mRNA vaccines, CAR-T therapies, adeno-associated virus gene therapies, and CRISPR-based treatments is increasing demand across research, process development, and quality-controlled manufacturing. Suppliers are differentiating through higher cell viability, reduced cytotoxicity, scalable platforms, animal-origin-free chemistries, closed-system compatibility, and application-specific protocols.
Technology and Workflow Shifts
These insights support strategic planning by clarifying where scalable, regulatory-aligned solutions are replacing general-purpose laboratory products.
Artificial Intelligence in Transfection
Artificial intelligence is improving experimental design, protocol optimization, and quality prediction. Machine learning can evaluate cell type, payload, reagent ratio, pulse parameters, viability, and expression outcomes to identify effective conditions with less trial and error-particularly valuable when working with limited patient-derived or primary-cell samples.
AI also supports formulation development, predictive instrument maintenance, automated image-based efficiency assessment, and digital quality control. Integration with laboratory information management systems, electronic lab notebooks, and imaging platforms can improve documentation and reduce workflow variability.
Regional Market Insights
Regional comparisons help organizations assess market-entry priorities, tailor pricing and training models, and mitigate regulatory or supply-chain risks.
Competitive and Commercial Priorities
Industry participants should build application-specific portfolios for mRNA delivery, CRISPR editing, immune-cell engineering, viral vector production, and transient protein expression. Key differentiators include validated protocols, difficult-cell performance, GMP documentation, lot-to-lot consistency, and smooth progression from discovery to manufacturing.
Investment in automation, digital protocol libraries, closed systems, and AI-enabled optimization can strengthen competitive positioning. Partnerships with contract development organizations, academic core facilities, hospitals, and cell therapy centers can accelerate adoption and generate credible application data.
Key Takeaways from This Report
Key Attributes:
Key Topics Covered:
1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Transfection Reagents & Equipment Market, by Product Type
7.1. Introduction
7.2. Transfection Reagents
7.2.1. Lipid-based Transfection Reagents
7.2.2. Polymer-Based Reagents
7.2.3. Calcium Phosphate Reagents
7.3. Transfection Equipment
7.3.1. Electroporation Systems
7.3.2. Microinjection Systems
8. Transfection Reagents & Equipment Market, by Technology Type
8.1. Introduction
8.2. Chemical Methods
8.3. Physical Methods
8.4. Viral Methods
9. Transfection Reagents & Equipment Market, by Molecule Type
9.1. Introduction
9.2. Plasmid DNA
9.3. shRNA
9.4. mRNA
9.5. CRISPR-Cas9 RNP complexes
9.6. Oligonucleotides
10. Transfection Reagents & Equipment Market, by Transfection Mode
10.1. Introduction
10.2. Transient Transfection
10.3. Stable Transfection
10.4. Episomal Expression Systems
11. Transfection Reagents & Equipment Market, by Application
11.1. Introduction
11.2. Gene Expression Studies
11.3. Protein Production
11.4. Drug Discovery & Development
11.5. Gene Therapy & Cell Therapy
11.6. Vaccine Development
12. Transfection Reagents & Equipment Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Transfection Reagents & Equipment Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Transfection Reagents & Equipment Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agilent Technologies, Inc.
16.2. Altogen Biosystems
16.3. Becton, Dickinson and Company
16.4. Bio-Rad Laboratories, Inc.
16.5. Bio-Techne Corporation
16.6. Biontex Laboratories GmbH
16.7. Celetrix LLC
16.8. GeneCopoeia Inc.
16.9. Lonza Group AG
16.10. MaxCyte, Inc.
16.11. Merck KGaA
16.12. Mirus Bio LLC
16.13. Novogene Corporation
16.14. OriGene Technologies, Inc.
16.15. Polyplus-transfection SA
16.16. Promega Corporation
16.17. QIAGEN N.V.
16.18. Revvity
16.19. Roche Holding AG
16.20. Sartorius AG
16.21. SignaGen Laboratories
16.22. Takara Bio Inc.
16.23. Thermo Fisher Scientific Inc.
17. Key Experts
List of Figures [21]
List of Tables [297]
For more information about this report visit https://www.researchandmarkets.com/r/wi6ase
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.